Literature DB >> 28118209

Menstrual and reproductive factors in the risk of thyroid cancer in Japanese women: the Japan Public Health Center-Based Prospective Study.

Sangah Shin1,2,3,4, Norie Sawada2, Eiko Saito1,2, Taiki Yamaji2, Motoki Iwasaki2, Taichi Shimazu2, Shizuka Sasazuki2, Manami Inoue1,2, Shoichiro Tsugane2.   

Abstract

The aim of this study was to evaluate the associations between menstrual and reproductive factors and thyroid cancer risk among Japanese women. A total 54 776 women aged 40-69 years completed a self-administered questionnaire, which included menstrual and reproductive history. During 1990-2012, 187 newly diagnosed cases of thyroid cancer were identified. Hazard ratios (HRs) and 95% confidence intervals (CIs) for menstrual and reproductive factors and incidence of thyroid cancer were estimated using Cox proportional hazards regression. Postmenopausal women who had natural menopause were at reduced risk of thyroid cancer than premenopausal women in the age-area-adjusted model (HR: 0.62 per 1 year increase, 95% CI: 0.39-0.99), but this association was slightly attenuated and no longer statistically significant in the multivariable-adjusted model. On analysis by menopausal status, an inverse association between age at menarche and risk of thyroid cancer was observed for premenopausal women (HR: 0.83 per 1 year increase, 95% CI: 0.70-0.98, P trend=0.03), but not for postmenopausal women. The risk of thyroid cancer increased with surgical menopause compared with natural menopause (HR: 2.34, 95% CI: 1.43-3.84). Although increasing age at menopause and duration of fertility were associated with an increased risk of thyroid cancer, this association was not observed among postmenopausal women. This study confirmed that early age at menarche for premenopausal women and surgical menopause and late age at natural menopause for postmenopausal women were associated with the development of thyroid cancer. Our results support the hypothesis that exposure to estrogens increases the risk of thyroid cancer.

Entities:  

Mesh:

Year:  2018        PMID: 28118209     DOI: 10.1097/CEJ.0000000000000338

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  5 in total

1.  Epidemiology of Thyroid Cancer.

Authors:  Cari M Kitahara; Arthur B Schneider
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-07-01       Impact factor: 4.090

2.  Thyroid Cancer Epidemiology in South Spain: a population-based time trend study.

Authors:  Elena Salamanca-Fernández; Miguel Rodriguez-Barranco; Yoe-Ling Chang-Chan; Daniel Redondo-Sánchez; Santiago Domínguez-López; Eloísa Bayo; Dariusz Narankiewicz; José Expósito; María José Sánchez
Journal:  Endocrine       Date:  2018-07-24       Impact factor: 3.633

3.  Risk of thyroid cancer in relation to height, weight, and body mass index in Japanese individuals: a population-based cohort study.

Authors:  Junya Sado; Tetsuhisa Kitamura; Tomotaka Sobue; Norie Sawada; Motoki Iwasaki; Shizuka Sasazuki; Taiki Yamaji; Taichi Shimazu; Shoichiro Tsugane
Journal:  Cancer Med       Date:  2018-03-25       Impact factor: 4.452

4.  Menstrual, reproductive and hormonal factors and thyroid cancer: a hospital-based case-control study in China.

Authors:  Meng Wang; Wei-Wei Gong; Qing-Fang He; Ru-Ying Hu; Min Yu
Journal:  BMC Womens Health       Date:  2021-01-06       Impact factor: 2.809

5.  Impact of thyroid cancer treatment on assisted reproductive technology outcomes in women with infertility.

Authors:  Ning Huang; Lin Zeng; Jie Yan; Hongbin Chi; Jie Qiao
Journal:  J Assist Reprod Genet       Date:  2021-04-26       Impact factor: 3.412

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.